sapropterin dihydrochloride

Generic: sapropterin dihydrochloride

Labeler: endo usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sapropterin dihydrochloride
Generic Name sapropterin dihydrochloride
Labeler endo usa, inc.
Dosage Form POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients

sapropterin dihydrochloride 100 mg/1

Manufacturer
ENDO USA, Inc.

Identifiers & Regulatory

Product NDC 49884-948
Product ID 49884-948_15ef488b-5a37-4338-a3f9-de0404549bd3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207207
Listing Expiration 2026-12-31
Marketing Start 2020-10-01

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] p-glycoprotein inhibitors [moa] phenylalanine hydroxylase activator [epc] phenylalanine hydroxylase activators [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49884948
Hyphenated Format 49884-948

Supplemental Identifiers

RxCUI
1111018
UPC
0349884948528 0349884948726
UNII
RG277LF5B3

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sapropterin dihydrochloride (source: ndc)
Generic Name sapropterin dihydrochloride (source: ndc)
Application Number ANDA207207 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 PACKET in 1 CARTON (49884-948-72) / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-948-52)
source: ndc

Packages (1)

Ingredients (1)

sapropterin dihydrochloride (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "15ef488b-5a37-4338-a3f9-de0404549bd3", "openfda": {"upc": ["0349884948528", "0349884948726"], "unii": ["RG277LF5B3"], "rxcui": ["1111018"], "spl_set_id": ["6b2172e4-42fc-42fe-b1ad-9d6a974d4343"], "manufacturer_name": ["ENDO USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (49884-948-72)  / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-948-52)", "package_ndc": "49884-948-72", "marketing_start_date": "20201001"}], "brand_name": "SAPROPTERIN DIHYDROCHLORIDE", "product_id": "49884-948_15ef488b-5a37-4338-a3f9-de0404549bd3", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Phenylalanine Hydroxylase Activator [EPC]", "Phenylalanine Hydroxylase Activators [MoA]"], "product_ndc": "49884-948", "generic_name": "SAPROPTERIN DIHYDROCHLORIDE", "labeler_name": "ENDO USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SAPROPTERIN DIHYDROCHLORIDE", "active_ingredients": [{"name": "SAPROPTERIN DIHYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA207207", "marketing_category": "ANDA", "marketing_start_date": "20201001", "listing_expiration_date": "20261231"}